Glenn Goddard

Insider Reports History

Location
Cambridge, MA
Signature
James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Glenn Goddard:

Company Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. EVP, Chief Financial Officer Common Stock 69,213 $2,033,478 $29.38 01 Mar 2024 Direct
Intellia Therapeutics, Inc. EVP, Chief Financial Officer Restricted Stock Unit 3,064 $73,230 $23.90 01 Jan 2024 Direct
Intellia Therapeutics, Inc. EVP, Chief Financial Officer Stock Option (right to buy) 41,316 01 Mar 2024 Direct

Insider Reports Filed by Glenn Goddard

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NTLA Intellia Therapeutics, Inc. 01 Mar 2024 2 $0 4 EVP, Chief Financial Officer 05 Mar 2024, 16:10
NTLA Intellia Therapeutics, Inc. 03 Jan 2024 1 -$158,053 4 EVP, Chief Financial Officer 05 Jan 2024, 16:49
NTLA Intellia Therapeutics, Inc. 01 Jan 2024 2 $0 4 EVP, Chief Financial Officer 03 Jan 2024, 17:28
NTLA Intellia Therapeutics, Inc. 01 Mar 2023 2 $0 4 EVP, Chief Financial Officer 03 Mar 2023, 16:20
NTLA Intellia Therapeutics, Inc. 04 Jan 2023 1 -$90,309 4 EVP, Chief Financial Officer 06 Jan 2023, 16:23
NTLA Intellia Therapeutics, Inc. 01 Jan 2023 2 $0 4 EVP, Chief Financial Officer 04 Jan 2023, 19:29
NTLA Intellia Therapeutics, Inc. 01 Mar 2022 1 $0 4/A EVP, Chief Financial Officer 04 Mar 2022, 20:04
NTLA Intellia Therapeutics, Inc. 01 Jan 2022 5 -$113,699 4 EVP, Chief Financial Officer 03 Mar 2022, 18:38
NTLA Intellia Therapeutics, Inc. 07 Sep 2021 3 -$576,410 4 EVP, Chief Financial Officer 09 Sep 2021, 17:38
NTLA Intellia Therapeutics, Inc. 30 Aug 2021 15 -$4,213,959 4 EVP, Chief Financial Officer 01 Sep 2021, 19:30
NTLA Intellia Therapeutics, Inc. 05 Aug 2021 5 -$2,635,656 4 EVP, Chief Financial Officer 06 Aug 2021, 18:17